Fukasawa H - Search Results

1

Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury.

Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S, Itai A, Isobe M. Onai Y, et al. Among authors: fukasawa h. Cardiovasc Res. 2004 Jul 1;63(1):51-9. doi: 10.1016/j.cardiores.2004.03.002. Cardiovasc Res. 2004. PMID: 15194461

2

Aldosterone-induced kidney injury is mediated by NFκB activation.

Fukuda S, Horimai C, Harada K, Wakamatsu T, Fukasawa H, Muto S, Itai A, Hayashi M. Fukuda S, et al. Among authors: fukasawa h. Clin Exp Nephrol. 2011 Feb;15(1):41-9. doi: 10.1007/s10157-010-0373-1. Epub 2010 Nov 12. Clin Exp Nephrol. 2011. PMID: 21072674 Free PMC article.

3

Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method.

Kato T, Ohara T, Suzuki N, Muto S, Tokuyama R, Mizutani M, Fukasawa H, Matsumura KI, Itai A. Kato T, et al. Among authors: fukasawa h. Bioorg Med Chem Lett. 2022 Mar 1;59:128567. doi: 10.1016/j.bmcl.2022.128567. Epub 2022 Jan 19. Bioorg Med Chem Lett. 2022. PMID: 35063634

4

Novel thiazolidinedione derivatives with retinoid synergistic activity.

Ebisawa M, Kawachi E, Fukasawa H, Hashimoto Y, Itai A, Shudo K, Kagechika H. Ebisawa M, et al. Among authors: fukasawa h. Biol Pharm Bull. 1998 May;21(5):547-9. doi: 10.1248/bpb.21.547. Biol Pharm Bull. 1998. PMID: 9635519 Free article.

5

Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids.

Ohta K, Kawachi E, Inoue N, Fukasawa H, Hashimoto Y, Itai A, Kagechika H. Ohta K, et al. Among authors: fukasawa h. Chem Pharm Bull (Tokyo). 2000 Oct;48(10):1504-13. doi: 10.1248/cpb.48.1504. Chem Pharm Bull (Tokyo). 2000. PMID: 11045459

6

Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.

Endo Y, Shimazu M, Fukasawa H, Driedger PE, Kimura K, Tomioka N, Itai A, Shudo K. Endo Y, et al. Among authors: fukasawa h. Bioorg Med Chem Lett. 1999 Jan 18;9(2):173-8. doi: 10.1016/s0960-894x(98)00724-0. Bioorg Med Chem Lett. 1999. PMID: 10021922

7

Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.

Endo Y, Iijima T, Yamakoshi Y, Fukasawa H, Miyaura C, Inada M, Kubo A, Itai A. Endo Y, et al. Among authors: fukasawa h. Chem Biol. 2001 Apr;8(4):341-55. doi: 10.1016/s1074-5521(01)00016-3. Chem Biol. 2001. PMID: 11325590

8

Inhibition of IL-1-induced IL-6 production by synthetic retinoids.

Kagechika H, Kawachi E, Fukasawa H, Saito G, Iwanami N, Umemiya H, Hashimoto Y, Shudo K. Kagechika H, et al. Among authors: fukasawa h. Biochem Biophys Res Commun. 1997 Feb 13;231(2):243-8. doi: 10.1006/bbrc.1997.6087. Biochem Biophys Res Commun. 1997. PMID: 9070257

9

Inhibition of protein tyrosine kinase by 5-S-GAD, a novel antibacterial substance from an insect.

Hijikata M, Kobayashi A, Leem JY, Fukasawa H, Uehara Y, Natori S. Hijikata M, et al. Among authors: fukasawa h. Biochem Biophys Res Commun. 1997 Aug 18;237(2):423-6. doi: 10.1006/bbrc.1997.7110. Biochem Biophys Res Commun. 1997. PMID: 9268727

10

Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions.

Takahashi B, Ohta K, Kawachi E, Fukasawa H, Hashimoto Y, Kagechika H. Takahashi B, et al. Among authors: fukasawa h. J Med Chem. 2002 Aug 1;45(16):3327-30. doi: 10.1021/jm0255320. J Med Chem. 2002. PMID: 12139443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters